bioRxivCancer BiologyPreprint
Analysis of Differential Gene Expression and Core Canonical Pathways involved in the Epithelial to Mesenchymal Transition of Triple Negative Breast Cancer Cells by Ingenuity Pathway Analysis.
Abstract
Triple Negative Breast Cancer (TNBC) is a malignant form of cancer with very high mortality and morbidity. Epithelial to Mesenchymal Transition (EMT) is the most common pathophysiological change observed in cancer cells of epithelial origin that promotes metastasis, drug resistance and cancer stem cell formation. Since the information regarding differential gene expression in TNBC cells and cell signaling events leading to EMT is limited, this investigation was done by comparing transcriptomic data generated by RNA isolation and sequencing of a EMT model TNBC cell line in comparison to regular TNBC cells. RNA sequencing and Ingenuity Pathway Software Analysis (IPA) of the transcriptomic data revealed several upregulated and downregulated gene expressions along with novel core canonical pathways including Sirtuin signaling, Oxidative Phosphorylation and Mitochondrial dysfunction events involved in EMT changes of the TNBC cells.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression
M. Bagheri, G. A. Mohamed, … D. R. Pattabiraman·bioRxiv·Apr 19, 2023
- Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBC
Ramon Garcia‐Areas, Elodie Girard, … Thierry Dubois·Scientific ReportsPeer-reviewed·Apr 2, 2026
- Epithelial-Mesenchymal Transition is Associated with Altered Immune Composition and Cytotoxic Function in Triple-Negative Breast Cancer
Hanxu Lu, Meisam Bagheri, … Brock C. Christensen·Breast Cancer ResearchPeer-reviewed·Jul 16, 2026
- NPC1 confers metabolic flexibility in Triple Negative Breast Cancer
K. I. O'Neill, L.-W. Kuo, … J. K. Richer·bioRxiv·May 5, 2022
- ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity
Sofia Morazzo, Soraia Fernandes, … Giancarlo Forte·Frontiers in OncologyPeer-reviewed·Aug 27, 2025
- Primary cilia promote EMT-induced triple-negative breast tumor heterogeneity and resistance to therapy
Camille E. Tessier, Jennifer Derrien, … Vincent J. Guen·EMBO Molecular MedicinePeer-reviewed·Aug 26, 2025